Skip to Content
Merck
CN
  • Disassociation of histone deacetylase-3 from normal huntingtin underlies mutant huntingtin neurotoxicity.

Disassociation of histone deacetylase-3 from normal huntingtin underlies mutant huntingtin neurotoxicity.

The Journal of neuroscience : the official journal of the Society for Neuroscience (2013-07-19)
Farah H Bardai, Pragya Verma, Chad Smith, Varun Rawat, Lulu Wang, Santosh R D'Mello
ABSTRACT

Huntington's disease (HD) is caused by a polyglutamine expansion within the huntingtin (Htt) protein. Both loss of function of normal Htt and gain of a toxic function by the polyglutamine-expanded mutant Htt protein have been proposed to be responsible for HD, although the molecular mechanisms involved are unclear. We show that Htt is a neuroprotective protein in both HD-related and unrelated model systems. Neuroprotection by Htt is mediated by its sequestration of histone deacetylase-3 (HDAC3), a protein known to promote neuronal death. In contrast to the normal Htt, mutant Htt interacts poorly with HDAC3. However, expression of mutant Htt liberates HDAC3 from Htt, thus de-repressing its neurotoxic activity. Indeed, mutant Htt neurotoxicity is inhibited by the knockdown of HDAC3 and markedly reduced in HDAC3-deficient neurons. A reduction in Htt-HDAC3 interaction is also seen in neurons exposed to other apoptotic stimuli and in the striatum of R6/2 HD mice. Our results suggest that the robust interaction between Htt and HDAC3 along with the ability of mutant Htt to disrupt this association while not itself interacting with HDAC3 provides an explanation for both the loss-of-function and gain-of-toxic-function mechanisms proposed for HD. Moreover, our results identify HDAC3 as an essential player in mutant Htt-induced neurodegeneration.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-Histone Deacetylase 3 (HDAC3) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution